reports
Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 Fi...
Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 Filing Delisting to take effect on July 3, 2023; Company’s common stock is expected to begin trading on the OTC under the symbol SRGAQ DEERFIELD, Ill., June 23, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, announced today that on June 22, 2023, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”). Nasdaq has determined that du...
Surgalign Enters Into Definitive Agreement to Sell Global Hardware and...
Surgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale Process Under Chapter 11 of the U.S. Bankruptcy Code DEERFIELD, Ill., June 20, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) (“Surgalign” or the “Company”) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that the Company has entered into an asset purchase agreement (the “Asset Purchase Agreement”) to sell substantially all of its U.S. hardware and biomaterials assets...
Surgalign to Participate at ISASS 2023 – 23rd Annual Conference Sponso...
Surgalign to Participate at ISASS 2023 – 23rd Annual Conference Sponsored by the International Society for the Advancement of Spine Surgery and Medical Education Resources Company to showcase its upgraded HOLO Portal™ Surgical Guidance System and key products in its hardware spine and biologics portfolio DEERFIELD, Ill., May 23, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, announced today that it will be exhibiting at ISASS 2023 – the 23rd Annual ...
Surgalign Announces First Quarter 2023 Results and Provides Update on ...
Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations DEERFIELD, Ill., May 11, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced financial results for its 2023 first quarter ended March 31, 2023. 2023 First Quarter and Subsequent Corporate Highlights: Launch of HOLO™ AI Insights for Spine Imaging; collaboration with Dr. Alexander Vaccaro, Dr. Pierce Nunley and Spine Institute of Louisiana, and l...
Surgalign Announces Release of HOLO™ AI Insights for Neurovascular Res...
Surgalign Announces Release of HOLO™ AI Insights for Neurovascular Research New HOLO AI Insights application aims to advance research of neuroanatomy utilizing artificial intelligence DEERFIELD, Ill., May 08, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, is proud to announce today, the release of HOLO™ AI Insights for use in neurovascular research. HOLO AI Insights, initially launched in March 2023 for spine imaging, enables customers, partners, ...
Surgalign Schedules First Quarter 2023 Earnings Release for May 11, 20...
Surgalign Schedules First Quarter 2023 Earnings Release for May 11, 2023 DEERFIELD, Ill., May 04, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its plans to release financial results for its first quarter 2023 after the close of trading on May 11, 2023. Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (888) 437-3179 (U.S.) or 862-298-0702 (Internatio...
Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nun...
Surgalign To Collaborate with Dr. Alexander Vaccaro and Dr. Pierce Nunley to Advance HOLO™ AI Insights and its Artificial Intelligence Technologies DEERFIELD, Ill., May 03, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, is pleased to announce new collaborative alliances with Dr. Pierce Nunley and the Spine Institute of Louisiana, a prestigious medical facility and one of the top 20 patient-rated U.S. hospitals for best overall care, and Dr. Alexander...
Surgalign Announces Receipt of Nasdaq Deficiency Notice and Intends to...
Surgalign Announces Receipt of Nasdaq Deficiency Notice and Intends to Submit Plan to Regain Compliance DEERFIELD, Ill., April 13, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, announced today that on April 10, 2023, it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is no longer in compliance with the $10 million minimum stockholders’ equity requireme...
Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 R...
Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results DEERFIELD, Ill., March 30, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today reported operating results for its fourth quarter and full year 2022 ending December 31, 2022. 2022 Fourth Quarter and Subsequent 2023 Corporate Highlights: Expansion of HOLO Portal™ into Virginia and Texas; over 30 cases performed since commercial launchLaunched HOLO™ AI Insights, part of th...
Surgalign Schedules Fourth Quarter and Full Year 2022 Earnings Release...
Surgalign Schedules Fourth Quarter and Full Year 2022 Earnings Release for March 30, 2023 DEERFIELD, Ill., March 21, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its plans to release financial results for its fourth quarter and full year 2022 after the close of trading on March 30, 2023. Surgalign will host a conference call and audio webcast at 4:30 p.m. ET the same day. The conference call can be accessed by dialing (866) 604-161...
Surgalign Launches Next Generation Software for its HOLO Portal™ Surgi...
Surgalign Launches Next Generation Software for its HOLO Portal™ Surgical Guidance System and Expands Surgical Tool Integration to Drive Use Case Adoption The next iteration of HOLO Portal delivers advancements based on early clinical experience and insights from leading spine surgeons in the U.S. DEERFIELD, Ill., March 20, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced the first major upgrade of the HOLO Portal™ Surgical Guidance ...
Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2...
Surgalign to Host its 2023 Annual Meeting of Shareholders on June 1, 2023 DEERFIELD, Ill., March 16, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it will be hosting its 2023 Annual Meeting of Shareholders virtually, on Thursday, June 1, 2023 at 9 a.m. PT. Shareholders will be able to access the Company’s Proxy Statement and Annual Report on Form 10-K once they are filed with the Securities and Exchange Commission. Once filed,...
Surgalign Announces Release of HOLO™ AI Insights for Spine Imaging
Surgalign Announces Release of HOLO™ AI Insights for Spine Imaging Surgalign’s HOLO AI Insights aims to enhance clinical decision making through the power of AI technology DEERFIELD, Ill., March 13, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, is proud to announce the release of HOLO AI Insights. HOLO AI Insights enables customers, partners, and clinical researchers to take advantage of the Company’s HOLO artificial intelligence (AI) portfolio t...
Surgalign Provides Update on Corporate Restructuring Initiatives and C...
Surgalign Provides Update on Corporate Restructuring Initiatives and Confirms its Prior 2022 Revenue Guidance Company on track to achieve target cash savings of $30 - $35 million in 2023 vs 2022; expects to report 2022 revenue of approximately $82.0 million and end the year with a cash balance in excess of $16 million DEERFIELD, Ill., March 06, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today provided updates on its previously announced restru...
Surgalign to Participate at the 2023 AAOS Annual Meeting OrthoDome in ...
Surgalign to Participate at the 2023 AAOS Annual Meeting OrthoDome in Las Vegas Dr. Rick C. Sasso, renowned spinal surgeon to highlight Surgalign’s HOLO Portal™ Surgical Guidance System on the OrthoDome Panel on March 8, 2023 DEERFIELD, Ill., March 03, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced its participation at the 2023 American Academy of Orthopaedic Surgeons (“AAOS”) Annual Meeting, which will take place March 7-11, 2023 ...
Medical City Frisco is the Latest Hospital to Utilize Surgalign’s HOLO...
Medical City Frisco is the Latest Hospital to Utilize Surgalign’s HOLO Portal Surgical Guidance System This represents the first site in Texas; Medical City Frisco to leverage the benefits of HOLO Portal, the world’s first artificial intelligence (AI)-driven, augmented reality (AR) system for spine surgery DEERFIELD, Ill., March 02, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that Medical City Frisco, a world-class acute care ho...
Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Mil...
Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million Expands Xtant’s Product Offering with the Leading PMA-Approved Intralaminar Stabilization Device Strengthens Surgalign’s Balance Sheet as it Embarks on its Digital Health Strategy BELGRADE, Mont. and DEERFIELD, Ill., March 01, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, and Surgalign Holdings, Inc., (NASDAQ: SRGA), a global medical technology company focused on elevating the st...
Surgalign Announces 100th Case Completed Utilizing its Recently Launch...
Surgalign Announces 100th Case Completed Utilizing its Recently Launched Cortera™ Spinal Fixation System DEERFIELD, Ill., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced a key milestone for its recently introduced posterior fixation platform – the Cortera™ Spinal Fixation System. Surgalign received FDA 510(k) in August 2022 and Cortera and was introduced in a limited market release shortly thereafter. In a little over three ...
Surgalign™ Expands Adoption of its HOLO Portal™ Surgical Guidance Syst...
Surgalign™ Expands Adoption of its HOLO Portal™ Surgical Guidance System in Virginia Richmond, VA medical facility is fourth to clinically use HOLO Portal, the world’s first artificial intelligence (AI)-driven, augmented reality (AR) guidance system for spine surgery DEERFIELD, Ill., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced additional commercialization of its HOLO Portal surgical guidance system. The Company is plea...
Surgalign Announces Closing of $12.0 Million Registered Direct Offerin...
Surgalign Announces Closing of $12.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules DEERFIELD, Ill., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that the closing of its previously announced registered direct offering priced at the market under Nasdaq rules of 6,000,000 shares of the Company's common stock (or pre-funded warrants in lieu thereof) and Series A warrants to purchase up to 6,000,000...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.